Back to results
UnknownPhase 3

Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes

NCT04373967

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

The Second Hospital of Anhui Medical University

Hefei, Anhui, China

+45 additional locations

Contact

Dalong Zhu, doctor

025-68182432zhudalong@nju.edc.cn
View on ClinicalTrials.gov
Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes — TrialFind